Switch to:

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
BEHRS MELISSA KELLYEVP BD and Port&Alliance Mgmt2015-05-29Sell2,380120,635$3.849.14-33.59120,635 (Direct)
Bloom Olivia KyusukEVP, CFO
(Click for the stocks that their CFOs have bought)
2015-05-29Sell2,38074,588$3.849.14-33.5974,588 (Direct)
Hofstaetter ThomasDirector2015-03-18Sell70,00026,564$4.1287-37.826,564 (Direct)
Bloom Olivia KyusukEVP, CFO
(Click for the stocks that their CFOs have bought)
2014-05-29Sell3,37981,968$2.17.121.4381,968 (Direct)
BEHRS MELISSA KELLYEVP Portfolio & Alliance Mgmt2014-05-29Sell4,826143,015$2.110.1321.43143,015 (Direct)
BRADBURY DANIELDirector2014-05-09Buy142,776142,776$1.75249.8645.71142,776 (Direct)
BEHRS MELISSA KELLYEVP Portfolio & Alliance Mgmt2014-04-01Sell12,310147,841$2.1326.2219.72147,841 (Direct)
Bloom Olivia KyusukEVP, CFO
(Click for the stocks that their CFOs have bought)
2014-04-01Sell7,43585,347$2.1315.8419.7285,347 (Direct)
SCARLETT JOHN APresident and CEO
(Click for the stocks that their CEOs have bought)
2013-04-01Buy50,000125,000$1.0351.5147.57
125,000 (Family trust)
BEHRS MELISSA KELLYSVP Alliance and Prog Mgmt2013-01-17Sell28,2920$1.6546.6854.55
0 (By Geron 401(k) plan)
Kelsey Stephen MichaelEVP, R&D Head, CMO2012-05-30Sell9,300473,122$1.3712.7486.13473,122 (Direct)
EARP DAVIDSVP, Corp Transactions2012-05-30Sell27,155467,406$1.3737.286.13467,406 (Direct)
Bloom Olivia KyusukVP, Chief Acctg Officer2012-05-30Sell11,029147,782$1.3715.1186.13147,782 (Direct)
BEHRS MELISSA KELLYSVP Strategic Portfolio Mgmt2012-05-30Sell18,910405,151$1.3725.9186.13405,151 (Direct)
KILEY THOMASDirector2011-11-22Buy64,275249,784$1.56100.2763.46
249,784 (By Thomas D. Kiley and Nancy L.M. Kiley Revocable Trust)
EARP DAVIDChief Legal Counsel2011-06-14Sell25,262494,561$4.28108.12-40.42494,561 (Direct)
Bloom Olivia KyusukVP, Chief Acctg Officer2011-06-14Sell6,997158,811$4.2829.95-40.42158,811 (Direct)
Spink Katharine E.SVP Alliance Mgmt & Operations2011-06-14Sell22,591328,561$4.2896.69-40.42328,561 (Direct)
LEBKOWSKI JANESVP, Chief Scientific Officer2011-06-14Sell25,262568,154$4.28108.12-40.42568,154 (Direct)
Kelsey Stephen MichaelEVP, R&D Head, CMO2011-06-14Sell4,858476,773$4.2820.79-40.42476,773 (Direct)
BEHRS MELISSA KELLYSVP Strategic Portfolio Mgmt2011-06-14Sell25,262424,061$4.28108.12-40.42424,061 (Direct)
GREENWOOD DAVIDPresident, Interim CEO, CFO2011-06-14Sell34,005754,031$4.28145.54-40.42754,031 (Direct)
Bloom Olivia KyusukVP, Chief Acctg Officer2011-05-24Sell1,200165,808$4.475.36-42.95165,808 (Direct)
Spink Katharine E.SVP Prgm Mgmt, Cell Therapies2011-05-24Sell419351,152$4.471.87-42.95351,152 (Direct)
BEHRS MELISSA KELLYSVP Strategic Portfolio Mgmt2011-05-24Sell2,975449,323$4.4713.3-42.95449,323 (Direct)
EARP DAVIDSVP Bus Dev, Chief Patnt Couns2011-05-24Sell2,975519,823$4.4713.3-42.95519,823 (Direct)
LEBKOWSKI JANESVP, Chief Scientific Officer2011-05-24Sell2,975593,416$4.4713.3-42.95593,416 (Direct)
GREENWOOD DAVIDPresident, Interim CEO, CFO2011-05-24Sell4,462788,036$4.4719.95-42.95788,036 (Direct)
Kelsey Stephen MichaelEVP, CMO, Oncology2011-05-05Sell14,163364,131$4.8368.41-47.2364,131 (Direct)
Spink Katharine E.VP Operations, Regen Med Progs2010-06-02Sell8,18691,571$5.4344.45-53.04Link
LEBKOWSKI JANESVP, CSO Regen Med2010-06-02Sell10,617196,891$5.4357.65-53.04Link
BEHRS MELISSA KELLYSVP Oncology2010-06-02Sell10,617136,048$5.4357.65-53.04Link
EARP DAVIDSVP Bus Dev, Chief Patnt Couns2010-06-02Sell10,617203,298$5.4357.65-53.04Link
GREENWOOD DAVIDEVP and CFO2010-06-02Sell14,746259,998$5.4380.07-53.04Link
OKARMA THOMASPresident and CEO2010-06-02Sell18,874437,060$5.43102.49-53.04Link
Spink Katharine E.VP Operations, Regen Med Progs2010-05-24Sell38599,757$5.111.97-50.1Link
LEBKOWSKI JANESVP, CSO Regen Med2010-05-24Sell2,336207,508$5.1111.94-50.1Link
BEHRS MELISSA KELLYSVP Oncology2010-05-24Sell2,336146,665$5.1111.94-50.1Link
EARP DAVIDSVP Bus Dev, Chief Patnt Couns2010-05-24Sell2,336213,915$5.1111.94-50.1Link
GREENWOOD DAVIDEVP and CFO2010-05-24Sell3,503274,744$5.1117.9-50.1Link
OKARMA THOMASPresident and CEO2010-05-24Sell4,671455,934$5.1123.87-50.1Link
Kelsey Stephen MichaelEVP, CMO, Oncology2010-04-28Sell3,70736,293$5.6620.98-54.95Link
Spink Katharine E.VP Operations, Regen Med Progs2009-05-29Sell40010,142$6.352.54-59.84
OKARMA THOMASPresident and CEO2009-05-29Sell5,828300,605$6.3537.01-59.84
LEBKOWSKI JANESVP, CSO Regen Med2009-05-29Sell2,277119,844$6.3514.46-59.84
BEHRS MELISSA KELLYSVP Oncology2009-05-29Sell2,27759,001$6.3514.46-59.84
HARLEY CALVINVP, CSO Telomerase Tech2009-05-29Sell2,27769,036$6.3514.46-59.84
EARP DAVIDSVP Bus Dev, Chief Patnt Couns2009-05-29Sell2,277126,251$6.3514.46-59.84
GREENWOOD DAVIDEVP and CFO2009-05-29Sell3,416153,247$6.3521.69-59.84
Benedetti Fabio MSVP, Chief Med Off, Oncology2009-05-29Sell2,27738,060$6.3514.46-59.84
Spink Katharine E.VP Operations, Regen Med Progs2009-05-26Sell2,86410,542$6.7519.33-62.22
OKARMA THOMASPresident and CEO2009-05-26Sell46,669306,433$6.75315.02-62.22
BEHRS MELISSA KELLYSVP Oncology2009-05-26Sell6,81961,278$6.7546.03-62.22
LEBKOWSKI JANESVP, CSO Regen Med2009-05-26Sell14,092122,121$6.7595.12-62.22
HARLEY CALVINVP, CSO Telomerase Tech2009-05-26Sell10,00171,313$6.7567.51-62.22
GREENWOOD DAVIDEVP and CFO2009-05-26Sell19,320156,663$6.75130.41-62.22
EARP DAVIDSVP Bus Dev, Chief Patnt Couns2009-05-26Sell15,456128,528$6.75104.33-62.22
Benedetti Fabio MSVP, Chief Med Off, Oncology2009-04-03Sell5,19540,337$4.4423.07-42.57
BEHRS MELISSA KELLYSVP Oncology2009-02-02Sell14,7650$8.12119.89-68.6
WALKER JOHN PETERDirector2009-01-30Sell48,61739,119$8.28402.55-69.2
HARLEY CALVINVP and CSO2009-01-29Sell30,48999,157$7.09216.17-64.03
OKARMA THOMASPresident and CEO2009-01-05Sell12,512353,102$4.961.31-47.96
LEBKOWSKI JANESVP Regen Medicine2009-01-05Sell8,861149,906$4.943.42-47.96
BEHRS MELISSA KELLYSVP Oncology2009-01-05Sell8,86179,877$4.943.42-47.96
HARLEY CALVINVP and CSO2009-01-05Sell8,861125,698$4.943.42-47.96
GREENWOOD DAVIDEVP and CFO2009-01-05Sell10,732179,560$4.952.59-47.96
EARP DAVIDSVP Bus Dev, Chief Patnt Couns2009-01-05Sell8,861155,764$4.943.42-47.96
BEHRS MELISSA KELLYSVP Oncology2008-11-05Sell23,84588,738$4.0596.57-37.04
OKARMA THOMASPresident and CEO2008-01-04Sell13,166361,492$5.3470.31-52.25
LEBKOWSKI JANESVP Regen Medicine2008-01-04Sell8,911147,619$5.3447.58-52.25
BEHRS MELISSA KELLYSVP Oncology2008-01-04Sell8,91194,285$5.3447.58-52.25
HARLEY CALVINVP and CSO2008-01-04Sell8,911119,389$5.3447.58-52.25
GREENWOOD DAVIDEVP and CFO2008-01-04Sell11,039171,783$5.3458.95-52.25
EARP DAVIDSVP Bus Dev, Chief Patnt Couns2008-01-04Sell8,911154,818$5.3447.58-52.25
GREENWOOD DAVIDEVP and CFO2007-11-12Sell4,000179,245$7.228.8-64.58
HARLEY CALVINVP and CSO2007-05-18Sell30,00057,223$9.19275.7-72.25
BEHRS MELISSA KELLYVP, Oncology2006-01-09Sell8,44114,726$8.5672.25-70.21Link
LEBKOWSKI JANESVP, Regenerative Medicine2006-01-09Sell10,67638,508$8.5691.39-70.21Link
OKARMA THOMASPresident and CEO2006-01-09Sell12,32031,575$8.56105.46-70.21Link
HARLEY CALVINChief Scientific Officer2006-01-09Sell9,18316,070$8.5678.61-70.21Link
GREENWOOD DAVIDExecutive VP and CFO2006-01-09Sell12,18329,925$8.56104.29-70.21Link
EARP DAVIDSVP Bus Dev / Chf Patent Couns2006-01-09Sell11,32340,792$8.5696.92-70.21Link
KELLY MELISSAVP, Oncology2005-07-29Sell65,5715,716$10.88713.41-76.56Link
GREENWOOD DAVIDExecutive VP and CFO2005-07-20Sell30,00010,831$10.45313.5-75.6Link
HARLEY CALVINChief Scientific Officer2005-07-20Sell25,0005,918$10.46261.5-75.62Link
HARLEY CALVINChief Scientific Officer2005-01-13Sell9,92911,836$8.5785.09-70.25Link
OKARMA THOMASPresident and CEO2005-01-13Sell14,28318,766$8.57122.41-70.25Link
KELLY MELISSAVP, Oncology2005-01-13Sell8,64811,432$8.5774.11-70.25Link
LEBKOWSKI JANESVP, Regenerative Medicine2005-01-13Sell6,15428,748$8.5752.74-70.25Link
GREENWOOD DAVIDExecutive VP, CFO2005-01-13Sell13,80420,531$8.57118.3-70.25Link
EARP DAVIDSVP Bus Dev / Chf Patent Couns2005-01-13Sell9,23934,971$8.5779.18-70.25Link
MERIX BIOSCIENCE INC10% Owner2004-08-16Sell65,5004,541,100$5.57364.84-54.22Link
MERIX BIOSCIENCE INC10% Owner2004-08-13Sell47,0004,606,600$5.52259.44-53.8Link
MERIX BIOSCIENCE INC10% Owner2004-08-12Sell167,9004,653,600$5.95999.01-57.14Link
MERIX BIOSCIENCE INC10% Owner2004-08-11Sell42,0004,821,500$5.46229.32-53.3Link
MERIX BIOSCIENCE INC10% Owner2004-08-10Sell101,5004,863,500$5.28535.92-51.7Link
MERIX BIOSCIENCE INC10% Owner2004-08-06Sell35,0004,965,000$5.52193.2-53.8Link
KELLY MELISSAVP, Oncology2004-04-06Sell2,0294,244$9.619.48-73.44Link
GREENWOOD DAVIDSr. VP, Corp Dev and CFO2004-04-06Sell6,0006,788$9.5157.06-73.19Link
HARLEY CALVINChief Scientific Officer2004-04-01Sell6,3214,719$9.2358.34-72.37Link
STEIN ROBERT BDirector2003-12-01Sell20,6250$12.42256.16-79.47Link
STEIN ROBERT BDirector2003-09-23Sell15,0500$12.5188.13-79.6Link
STEIN ROBERT BDirector2003-09-10Sell23,4000$8.78205.45-70.96Link
GREENWOOD DAVIDSr. VP, Corp Dev and CFO2003-07-31Sell16,0113,333$8.24131.93-69.05Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column), "Shares Owned Following This (Direct & Indirect)" transactions (sixth column), and "Trade Price ($)" (seventh column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported (also split adjusted).

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK